Funds and ETFs Smith & Nephew Plc

Equities

SN.

GB0009223206

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe 08:21:01 2024-04-25 am EDT 5-day change 1st Jan Change
983.2 GBX -0.02% Intraday chart for Smith & Nephew Plc +1.59% -8.93%

ETFs positioned on Smith & Nephew Plc

Name Weight AuM 1st Jan change Investor Rating
1.16% 16 M€ -7.62%
0.52% 11 M€ +0.83% -
0.42% 18 M€ +3.04% -
0.14% 7 M€ +1.70% -
0.12% 6 M€ -.--%
0.08% 1,120 M€ +0.38%
0.06% 10 M€ -3.35% -
0.05% 31 M€ +3.05% -
0.03% 205 M€ -.--%
0.03% 284 M€ -.--%
0.03% 0 M€ 0.00% -
0.03% 273 M€ +14.37%
0.03% 786 M€ -.--%
0.03% 23 M€ -.--% -
0.02% 206 M€ -.--%
0.02% 1,166 M€ +0.26% -
0.02% 607 M€ +0.05% -
0.02% 389 M€ +5.61% -
0.02% 34 M€ +5.94% -
0.01% 302 M€ +3.48% -
0.01% 39 M€ +3.93% -
0.01% 17 M€ +1.15% -
0.01% 108 M€ +1.67% -
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows: - orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders); - sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.; - wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc. The United States accounts for 53.7% of net sales.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.23 USD
Average target price
16.41 USD
Spread / Average Target
+34.22%
Consensus
  1. Stock Market
  2. Equities
  3. SN. Stock
  4. Funds and ETFs Smith & Nephew Plc